Kinase inhibitor Sorafenib modulates immunosuppressive cell populations in a murine liver cancer model.

Cao, Mengde; Xu, Yiling; Youn, Je-in; Cabrera, Roniel; Zhang, Xiaokui; Gabrilovich, Dmitry; Nelson, David R; Liu, Chen

Cao, Mengde; Xu, Yiling; Youn, Je-in; Cabrera, Roniel; Zhang, Xiaokui; Gabrilovich, Dmitry; Nelson, David R; Liu, Chen.

Affiliation

Cao M; Department of Medicine, University of Florida, Gainesville, FL 32610, USA.

Lab Invest ; 91(4): 598-608, 2011 Apr.

Article in En | MEDLINE | ID: mdl-21321535

Subject(s)

Benzenesulfonates/pharmacology; Carcinoma, Hepatocellular/immunology; Carcinoma, Hepatocellular/pathology; Liver Neoplasms/immunology; Liver Neoplasms/pathology; Protein Kinase Inhibitors/pharmacology; Pyridines/pharmacology; Animals; Bone Marrow Cells/pathology; Cell Division/drug effects; Cell Line, Tumor; Disease Progression; Immunity, Cellular/drug effects; Mice; Mice, Inbred BALB C; Myeloid Cells/immunology; Myeloid Cells/pathology; Niacinamide/analogs & derivatives; Phenylurea Compounds; Sorafenib; Spleen/pathology; T-Lymphocytes, Regulatory/pathology

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyridines / Benzenesulfonates / Carcinoma, Hepatocellular / Protein Kinase Inhibitors / Liver Neoplasms Limits: Animals Language: En Journal: Lab Invest Year: 2011 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google